产品封面图
研选

现货Candor Bioscience:LowCross-B

uffer®(低交叉反应缓冲液/HAMA/RF阻断剂)
收藏
  • ¥1357 - 11362
  • Candor已认证
  • 德国
  • 100 050/125/500
  • 2026年01月27日
    快速发货
    快速回复
    售后服务
    技术支持
    文献支持
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 用户评价
    • 文献和实验
    • 技术资料
    • 保存条件

      2-8°C or -15 to -30°C

    • 保质期

      N/A

    • 英文名

      Candor Bioscience:LowCross-Buffer®

    • 库存

      部分现货库存

    • 供应商

      青木生物技术(武汉)有限公司

    • 规格

      50 ml/125 ml/500 ml

    规格:50 ml产品价格:¥1357.0
    规格:125 ml产品价格:¥3013.0
    规格:500 ml产品价格:¥11362.0
    The formulation of LowCross-Buffer® helps to reduce interference in immunoassays. Thus quality of detection can be significantly improved. Nonspecific binding of the antibodies, negative effects of interfering substances and low or medium affinity cross-reactivities of the antibodies are minimized. In addition matrix effects, coming for example from blood sera or plasma specimen are reduced. That means that matrix effects no longer exacerbate detection of analytes. Minimization of all these negative effects upgrades the quality of the assay and improves the reliability of the results.

    LowCross-Buffer® is free of phosphate.
    产品细节图片1 产品细节图片2 产品细节图片3

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标用户评价
      图标暂无用户评价
      图标文献和实验
      该产品被引用文献
      1. The challenges of serology - towards reliable SARS-CoV-2 antibody assays
      2. Specific antibodies reacting to JC polyomavirus capsid protein mimotopes in sera from multiple sclerosis and other neurological diseases‐affected patients
      3. Antibodies reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein, in sera from children
      4. Hierarchy in the Avidity and Cross-reactivity of Anti-citrullinated Protein Antibodies in the Serum of Patients With Rheumatoid Arthritis
      5. Expression Patterns Of Chloride Transporters In The Auditory Brainstem Of Developing Chicken
      6. Neutralizing antibody response in non-hospitalized SARS-CoV-2 patients
      7. Novel bioanalytical method for the characterization of the immune response directed against a bispecific F (ab) fragment
      8. Regulation of histamine and diamine oxidase in patients undergoing orthotopic liver transplantation
      9. Encoded particle microfluidic platform for rapid multiplexed screening and characterization of aptamers against influenza A nucleoprotein
      10. “Simulect” as a model compound for assessing placental transfer of monoclonal antibodies in minipigs
      11. Development of a real time immuno-PCR assay for the detection of pea root rot causal agent, Aphanomyces euteiches
      12. Towards an integrated system as point-of-care device for the optical detection of sepsis biomarkers
      13. A throughput serological Western blot system using whole virus lysate for the concomitant detection of antibodies against SARS-CoV-2 and human endemic Coronaviridae
      14. Method of detecting proteins in human samples and uses of such methods
      15. Correlation between the results of two analytical methods for measuring measles virus neutralizing antibodies in source plasma and therapeutic immunoglobulin products
      16. Use of Ella® to facilitate drug quantification and antidrug antibody detection in preclinical studies
      17. Fast and Efficient Fc-Specific Photoaffinity Labeling To Produce Antibody–DNA Conjugates
      18. Accurate SARS-CoV-2 seroprevalence surveys require robust multi-antigen assays
      19. Robust SARS-COV-2 serological population screens via multi-antigen rules-based approach
      20. A targeted mass spectrometry strategy for developing proteomic biomarkers: a case study of epithelial ovarian cancer
      21. MIBI-TOF: A multiplexed imaging platform relates cellular phenotypes and tissue structure
      22. CIS checkpoint deletion enhances the fitness of cord blood derived natural killer cells transduced with a chimeric antigen receptor
      23. SYSTEMS, COMPOSITIONS AND METHODS FOR DETECTING AND ANALYZING MICRO-RNA PROFILES FROM A BIOLOGICAL SAMPLE
      相关实验
      • 免疫分析中,遭遇HAMA等干扰问题如何破?

        数量的亲和力结合也会导致高分析读数,产生特定的假阳性结果,或者高背景和坏的信噪比。一种潜在的方法是使用高浓度的分析稀释剂来减少这些有问题的中低亲和力相互作用的影响。然而,这些高浓度的条件也会对高亲和力结合产生负面影响,从而影响分析的正确信号。因此,高浓度缓冲液不是一个有用的选择。 减少亲和力和中亲和力结合作用而不影响高亲和力结合的唯一方法是亲和力鉴别。15年前,CANDOR BIOSCIENCELowCross Buffer®产品成功引入了这种作用模式,此后消除了数百万样本中的干扰。如果用于

      • 二抗现货

        货号 品名 规格 价格 备注 C0701 柠檬酸盐溶液-即枸橼酸盐 2L/袋 7 10mM pH 6.0,背景着色 C0702 EDTA缓冲液 (50X) 50ml 45 1mM

      • CANDOR BIOSCIENCE: 关于ELISA板稳定性的技术探讨与比较

        商业化试剂盒的早期,应考虑其稳定性。简单的方法,如使用BSA作为稳定剂,对包被捕获分子的稳定性没有显著影响,并且无法保持板的功能性(Fig.1a)。更有效的是自20世纪80年代以来诊断生产中使用的的糖或碳水化合物溶液。这些溶液能够在确保持续制冷的情况下充分维持包被板的稳定性,从而成为第一个真正的固相稳定剂。这种以糖为基础的稳定剂通常可保持板的保质期在一年的范围内,但在此期间质量略有下降是常见的。由德国CANDOR BIOSCIENCE提供的Liquid Plate Sealer®(Fig.1b),与碳水

      研选
      现货Candor Bioscience:LowCross-Buffer®(低交叉反应缓冲液/HAMA/RF阻断剂)
      ¥1357 - 11362